| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $8.17B | $8.32B | $7.83B |
| YoY Revenue Growth % | -1.8% | +6.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.07B | $1.12B | $1.07B |
| Operating Margin % | 13.1% | 13.5% | 13.7% |
| Net Income (GAAP) | $842.0M | $887.0M | $852.0M |
| EBITDA (Normalized) | $1.37B | $1.42B | $1.35B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.53B | $1.15B | $1.97B |
| Capital Expenditures (CapEx) | $367.8M | $374.6M | $352.2M |
| Free Cash Flow (FCF) | $1.17B | $777.4M | $1.62B |
| FCF Margin % | 14.3% | 9.3% | 20.7% |
| Return on Invested Capital (ROIC %) | 5.4% | 5.9% | 14.9% |
| Cash & Short-Term Equivalents | $1.73B | $1.41B | — |
| Total Debt (Short + Long Term) | $12.52B | $11.87B | $2.20B |
| Total Stockholders' Equity | $4.82B | $4.47B | $4.51B |